CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RENASCENT project aims to develop a novel treatment for retinitis pigmentosa by formulating tideglusib for targeted delivery to the retina. This approach seeks to enhance therapeutic efficacy and accessibility for a broader patient population suffering from this condition.
Retinitis pigmentosa is one of the main causes of irreversible blindness worldwide, yet the only intraocular approved treatment, Luxturna®, is suitable for less than 1% of patients. A promising way to tackle this disease is by targeting protein aggregation, a process involved in all forms of retinitis pigmentosa and other brain-related disorders.
Most potential treatments are still in early stages, so repurposing existing drugs with known safety records can speed up the development of effective…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Alicante
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
